293 studies found for:    Encephalitis
Show Display Options
Download search resultsDownload the search results for:
Encephalitis (293 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Enrolling by invitation Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers
Conditions: Encephalitis;   Japanese Encephalitis
Intervention:
3 Completed
Has Results
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: Japanese encephalitis chimeric virus vaccine (JE-CV);   Biological: Japanese encephalitis live vaccine (SA14-14-2 vaccine) (CD.JEVAX®)
4 Completed A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Conditions: Japanese Encephalitis;   Japanese Encephalitis Vaccine
Intervention: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2
5 Completed
Has Results
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers
Conditions: Japanese Encephalitis;   Japanese Encephalitis Virus Disease
Interventions: Biological: Live attenuated Japanese encephalitis chimeric virus vaccine;   Biological: Japanese encephalitis live attenuated vaccine (SA14 14 2 vaccine)
6 Completed
Has Results
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: ChimeriVax-JE, Japanese Encephalitis vaccine;   Biological: 0.9% Saline
7 Completed A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
Conditions: Chronic Focal Encephalitis;   Rasmussen's Encephalitis
Intervention: Drug: Rituximab
8 Completed
Has Results
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population
Condition: Encephalitis
Interventions: Biological: IC51 Japanese Encephalitis;   Biological: Havrix®720;   Biological: Prevnar
9 Active, not recruiting Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries
Condition: Encephalitis
Intervention: Biological: IC51
10 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
11 Completed Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
Conditions: Japanese Encephalitis;   Measles;   Mumps;   Rubella
Intervention: Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus
12 Active, not recruiting Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV
Conditions: Japanese Encephalitis;   Varicella
Interventions: Biological: Japanese encephalitis chimeric virus;   Biological: Varicella vaccine
13 Completed Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine
14 Completed Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Live attenuated SA 14-14-2 vaccine
15 Completed
Has Results
A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: Live attenuated Japanese encephalitis virus, then ChimeriVax diluent;   Biological: ChimeriVax diluent, then Live attenuated Japanese encephalitis virus
16 Enrolling by invitation Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan
Condition: Japanese Encephalitis
Intervention:
17 Completed Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
18 Completed Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis
Condition: Japanese Encephalitis
Interventions: Biological: Mouse brain derived japanese encephalitis vaccine (MB-JEV);   Biological: Primary and booster immunizations with MB-JEV;   Biological: C) primary immunizations with Ixiaro;   Biological: S) Ixiaro booster to MBJEV primed
19 Completed Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
Conditions: Japanese Encephalitis;   Hepatitis A
Interventions: Biological: Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28);   Biological: Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)
20 Completed Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines
Conditions: Japanese Encephalitis;   Hepatitis A
Interventions: Biological: Japanese encephalitis vaccine;   Biological: Japanese encephalitis vaccine (Acambis);   Biological: Hepatitis A vaccine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years